News

Currently recruiting for Riociguat clinical trial

Currently recruiting for Riociguat clinical trial

Drs. Kato and Gladwin are now recruiting participants for the Multi-Center Study of Riociguat in Sickle Cell Patients trial.   For more information, or to see if you qualify, please contact Carolyn Newkirk at 412-692-2437 or can59@pitt.edu. You can also find...

read more
Vodacom Foundation donates mobile phones for study

Vodacom Foundation donates mobile phones for study

Exciting news from collaborators in Tanzania!  The MDOTtrial ,whose main intervention is self-video recording of the participant while taking medication, requires the use of mobile smart phones.  However, due to budget, the study was not able to purchase mobile smart...

read more
A New Way to Model Sickle Cell Behavior

A New Way to Model Sickle Cell Behavior

Dr. Greg Kato is part of a team, led by CMU President Subra Suresh, that recently developed a new way to model sickle cell behavior. READ MORE... <table width="720" border="0" cellspacing="0" cellpadding="0"><!-- [et_pb_line_break_holder] -->...

read more
Children’s Sickle Cell Foundation Visits VMI

Children’s Sickle Cell Foundation Visits VMI

We were honored to have the Children’s Sickle Cell Foundation, local sickle cell patients, and other partners tour research laboratories as part of the Living Well with Sickle Cell® Family Research Summit. WATCH the video below. <table width="720" border="0"...

read more